# Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.

> **NCT06968546** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fondation Lenval** · enrollment: 116 (estimated)

## Conditions studied

- Traumatology
- Wounds and Injury
- Fractures Bone
- Analgesia
- Pain
- Pain Management
- Acute Pain

## Interventions

- **DRUG:** Intranasal Sufentanil
- **DRUG:** Intranasal Ketamine (IN)

## Key facts

- **NCT ID:** NCT06968546
- **Lead sponsor:** Fondation Lenval
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02-05
- **Primary completion:** 2028-03-31
- **Final completion:** 2028-03-31
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06968546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06968546, "Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06968546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*